Indian clinical practice consensus guidelines for the management of oral cavity cancer: Update 2022

The treatment of oral cavity cancer primarily depends on the location, tumor size, and feasibility of organ preservation in patients with negative margins. A liquid biopsy is a minimally invasive approach for detecting blood-based signatures such as circulating tumor cells (CTCs) and circulatory tum...

Full description

Saved in:
Bibliographic Details
Published inCancer research, statistics, and treatment (Online) Vol. 7; no. Suppl 1; pp. S6 - S11
Main Authors Chaturvedi, Pankaj, Prabhash, Kumar, Babu, K Govind, Kuriakose, Moni, Birur, Praveen, Anand, Anil K., Kaushal, Ashish, Mahajan, Abhishek, Syiemlieh, Judita, Singhal, Manish, Gairola, Munish, Ramachandra, Prakash, Goyal, Sumit, John, Subashini, Nayyar, Rohit, Patil, Vijay M, Rao, Vishal, Noronha, Vanita, Roshan, Vikas, Rath, G.K.
Format Journal Article
LanguageEnglish
Published India Wolters Kluwer - Medknow 01.01.2024
Edition2
Subjects
Online AccessGet full text
ISSN2590-3233
2590-3225
DOI10.4103/crst.crst_119_23

Cover

More Information
Summary:The treatment of oral cavity cancer primarily depends on the location, tumor size, and feasibility of organ preservation in patients with negative margins. A liquid biopsy is a minimally invasive approach for detecting blood-based signatures such as circulating tumor cells (CTCs) and circulatory tumor DNA (ctDNA). To assess the presence of occult metastatic disease, sentinel lymph node biopsy (SLNB) is recommended in early-stage oral cavity cancer (OCC). In India, surgery is the preferred choice of treatment for oral cancers. Selected patients, who are medically inoperable or refuse surgery, should be given definitive radiotherapy (RT) as an alternative to surgery. Concurrent chemoradiation (CCRT) may be considered an alternative option to definitive RT in patients with unresectable oral cancer.
ISSN:2590-3233
2590-3225
DOI:10.4103/crst.crst_119_23